Biobanking of Human Biospecimens
Description
More details
Other editions
New editions
Additional editions
Persons
Pierre Hainaut, Ph.D., is Professor of Cancer Biology and holds a Chair of Excellence in Translational Cancer Research at University Grenoble-Alpes, France. As head of Molecular Carcinogenesis at the International Agency for Research on Cancer (IARC, World Health Organization, Lyon, France), he has led the development of international standards for biobanking in the fields of molecular epidemiology and pathology, and has been involved in many projects implementing biomarkers in international molecular epidemiological studies in Africa, Asia or Latin America. Currently, he is the Director of the Institute for Advanced Biosciences, a joint research center of the French National Institute of Health and Medical Research (INSERM), National Center for Scientific Research (CNRS) and Université Grenoble-Alpes, dedicated to Epigenetics, Chronic Diseases and Cancer. He is also responsible for Molecular Diagnosis of Cancer at the University Hospital of Grenoble-Alpes, France. His research focuses on TP53 mutations and on biomarkers of transition from chronic diseases to cancer.
Jim Vaught, Ph.D., spent 14 years at the U.S. National Cancer Institute (NCI), most recently as the Chief of the Biorepositories and Biospecimen Research Branch (BBRB) in the Cancer Diagnosis Program. He's one of the founding members of the International Society for Biological & Environmental Repositories (ISBER) and was its second President. He has provided biobanking consulting services to a variety of international organizations, and serves on a number of biobank advisory groups. He was Senior Editor for Biospecimens and Biorepositories for the AACR journal Cancer Epidemiology, Biomarkers and Prevention and is the Editor-in-Chief of Biopreservation and Biobanking, the official journal of ISBER. He is currently a Senior Research Fellow at the International Prevention Research Institute (Lyon). Dr. Vaught is the immediate Past-President of ISBER and a member of the Board of Directors.
Kurt Zatloukal, MD, is Professor of Pathology at the Medical University of Graz. He coordinated the preparatory phase of a European biobanking and biomolecular resources research infrastructure (BBMRI) within the 7th EU framework programme, and is the National Node Director of BBMRI. His research fields are molecular pathology of liver diseases and cancer, and the development of biobanking technologies.
Markus Pasterk is Administrative Director of BBMRI-ERIC, the pan-European Research Infrastructure for Biobanking and Biomolecular Resources with Headquarters in Graz, Austria. Before that he was Chief Operating Officer and Vice President/Science, at the International Prevention Research Institute in Lyon, France and Scientific Coordinator of the International Agency for Research of Cancer in Lyon, France. He is an expert in research and E&T management.Content
.- 1. 20 years of biobanking: dawning or a new era (Volume Editors) .- SECTION 1: BIOBANKS IN PRACTICE.- 2. Principles of cryo-preservation-Allison Hubel (University of Minnesota).- 3. Biobank design and infrastructure-A. Zaayenga (SmarterLab Inc).- 4. Minimal standards for biobank annotations-H.M. Moore (National Cancer Institute).- 5. Biobank governance and sustainability- M. Pasterk (IPRI, France).- 6. Biobanking in low resource contexts-R. Lawlor (University of Verona).- 7. Biosafety and biosecurity -G. D'Agnolo (Italian National Committee on Biosafety, Biotechnology and Life Sciences).- 8. Quality assurance and quality control in Biobanking- Di Donato (INSERM, France).- 9. Biocomputing for biobanks-P. Fearn (University of Washington).- 10. Ethical and societal challenges for biobanks-Jane Kay (INSERM, France).- SECTION 2: TYPES OF BIOBANKS.- 11. Disease-oriented biobanks: from pathology archives to personalized medicine-Peter Riegman (Erasmus University).- 12. Biobanking for molecular epidemiology- J.Dillner (Helmoltz, Munich). .- 13. Biobanking for biomarker discovery- Jim Vaught (National Cancer Institute).- 14. Biobanking in clinical trials- G. Golfinopoulos (EORTC, Belgium).- 15. Industrial Biobanks-(To Be Defined). .- SECTION 3: NETWORKING BIOBANKS.- 16. International biobank networks: the P3G experience-I. Fortier (McGill University).- 17. Networking Biobanks throughout Europe- KurtEero Vuorio (INSERM, France).- 18. Biobanking networks through 5 continents -R. Hewitt, N. Zeps.- 19. Driving international convergence through evidence-based standards (Volume Editors). .- 20. National Networking - the case of Spain- Morente Manuel (CNIO, Madrid).- SECTION 4: The Future of Biobanking.- 21. Training biobankers for the 21st century-E. Gormally (Fac Catholique, France).- 22. The Science of Biobanking and biospecimen research- Jim Vaught (National Cancer Institute).- 23. Economics of Biobanking-Jim Vaught (National Cancer Institute).- 24. Meeting Tomorrow's Challenges: Biobanking for All (Volume Editors).